|
1
|
Jansen AP, Camalier CE and Colburn NH:
Epidermal expression of the translation inhibitor programmed cell
death 4 suppresses tumorigenesis. Cancer Res. 65:6034–6041. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hilliard A, Hilliard B, Zheng SJ, et al:
Translational regulation of autoimmune inflammation and lymphoma
genesis by programmed cell death 4. J Immunol. 177:8095–8102. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang HS, Matthews CP, Clair T, et al:
Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated
protein kinase kinase kinase kinase 1 expression to suppress colon
carcinoma cell invasion. Mol Cell Biol. 26:1297–1306. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soejima H, Miyoshi O, Yoshinaga H, et al:
Assignment of the programmed cell death 4 gene (Pdcd4) to human
chromosome band 10q24 by in situ hybridization. Cytogenet Cell
Genet. 87:113–114. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cmarik JL, Min H, Hegamyer G, et al:
Differentially expressed protein Pdcd4 inhibits tumor
promoter-induced neoplastic transformation. Proc Natl Acad Sci USA.
96:14037–14042. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bitomsky N, Bohm M and Klempnauer KH:
Transformation suppressor protein Pdcd4 interferes with
JNK-mediated phosphorylation of c-Jun and recruitment of the
coactivator p300 by c-Jun. Oncogene. 23:7484–7493. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goke R, Barth P, Schmidt A, Samans B and
Lankat-Buttgereit B: Programmed cell death protein 4 suppresses
CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell
Physiol. 287:1541–1546. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leupold JH, Yang HS, Colburn NH, Asangani
I, Post S and Allgayer H: Tumor suppressor Pdcd4 inhibits
invasion/intravasation and regulates urokinase receptor (u-PAR)
gene expression via Sp-transcription factors. Oncogene.
26:4550–4562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang HS, Jansen AP, Nair R, et al: A novel
transformation suppressor, Pdcd4, inhibits AP-1 transactivation but
not NF-κB or ODC transactivation. Oncogene. 20:669–676.
2001.PubMed/NCBI
|
|
10
|
Yang HS, Knies JL, Stark C and Colburn NH:
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1
transactivation. Oncogene. 22:3712–3720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li T, Li D, Sha J, Sun P and Huang Y:
MicroRNA-21 directly targets MARCKS and promotes apoptosis
resistance and invasion in prostate cancer cells. Biochem Biophys
Res Commun. 383:280–285. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wen YH, Shi X, Chiriboga L, Matsahashi S,
Yee H and Afonja O: Alterations in the expression of Pdcd4 in
ductal carcinoma of the breast. Oncol Rep. 18:1387–1393.
2007.PubMed/NCBI
|
|
13
|
Wei NA, Liu SS, Leung TH, et al: Loss of
Programmed cell death 4 (Pdcd4) associates with the progression of
ovarian cancer. Mol Cancer. 8:702009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bohm M, Sawicka K, Siebrasse JP,
Brehmer-Fastnacht A, Peters R and Klempnauer KH: The transformation
suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and
binds RNA. Oncogene. 22:1905–1910. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lankat-Buttgereit B, Gregel C, Knolle A,
Hasilik A, Arnold R and Goke R: Pdcd4 inhibits growth of tumor
cells by suppression of carbonic anhydrase type II. Mol Cell
Endocrinol. 214:149–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park JK, Hong R, Kim KJ, Lee TB and Lim
SC: Significance of p-STAT3 expression in human colorectal
adenocarcinoma. Oncol Rep. 20:597–604. 2008.PubMed/NCBI
|
|
17
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Manual. 6th edition. Springer-Verlag; New York:
pp. 157–164. 2002
|
|
18
|
Mudduluru G, Medved F, Grobholz R, et al:
Loss of programmed cell death 4 expression marks adenoma-carcinoma
transition, correlates inversely with phosphorylated protein kinase
B, and is an independent prognostic factor in resected colorectal
cancer. Cancer. 110:1697–1707. 2007. View Article : Google Scholar
|
|
19
|
Yang HS, Jansen AP, Komar AA, et al: The
transformation suppressor Pdcd4 is a novel eukaryotic translation
initiation factor 4A binding protein that inhibits translation. Mol
Cell Biol. 23:26–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Knosel T, Kristiansen G, et al:
Loss of Pdcd4 expression in human lung cancer correlates with
tumour progression and prognosis. J Pathol. 200:640–646. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshinaga H, Matsuhashi S, Fujiyama C and
Masaki Z: Novel human Pdcd4 (H731) gene expressed in proliferative
cells is expressed in the small duct epithelial cells of the breast
as revealed by an anti-H731 antibody. Pathol Int. 49:1067–1077.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Palamarchuk A, Efanov A, Maximov V,
Aqeilan RI, Croce CM and Pekarsky Y: Akt phosphorylates and
regulates Pdcd4 tumor suppressor protein. Cancer Res.
65:11282–11286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Ozaki I, Mizuta T, et al:
Involvement of programmed cell death 4 in transforming growth
factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Oncogene. 25:6101–6112. 2005. View Article : Google Scholar : PubMed/NCBI
|
